Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Arbutus Biopharma (NASDAQ:ABUS) Upgraded to “Buy” by StockNews.
Finally, JMP Securities reaffirmed a market outperform rating and set a $6.00 price objective on shares of Arbutus Biopharma in a report on Wednesday, March 29th.
He’s alleged to be behind the death of a 24-year-old, who was crossing West 4th Avenue at Arbutus Street with a friend on June 19, 2022.
Source: https://www.abbynews.com/news/26-year-old-charged-in-fatal-kitsilano-hit-and-run/
Moneta Group Investment Advisors LLC raised its position in Arbutus Biopharma by 49.1% during the first quarter.